Brief: Nordic Nanovector Q3 Comprehensive Loss Widens To NOK 93.6 Million

Thor Medical ASA

19/11/2019 06:22

Nov 19 (Reuters) - Nordic Nanovector ASA  NANOV.OL :
    * RESULTS FOR THE THIRD QUARTER 2019
    * Q3 COMPREHENSIVE LOSS NOK 93.6 MILLION VERSUS LOSS NOK
75.4
MILLION YEAR AGO
    * "WE ARE ENCOURAGED WITH CLINICAL RESULTS EMERGING FROM
DIFFERENT
CLINICAL TRIALS WITH BETALUTIN® IN NON-HODGKIN'S LYMPHOMA (NHL)"
-CEO
    * IS ALSO EVALUATING OPPORTUNITIES WITH OTHER CD37-TARGETING
RADIOIMMUNOTHERAPIES ACROSS NHL AND OTHER HAEMATOLOGICAL CANCER
INDICATIONS

Source text for Eikon:  ID:nObivpyKXa 
Further company coverage:  NANOV.OL 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))